Evidence map›Paper›PMID 24963795›Full record

ReviewNitric oxide : biology and chemistry2014

Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator.

Utpal Sen, Sathnur B Pushpakumar, Matthew A Amin, Suresh C Tyagi

Open access · greenAbstract readReview
In one paragraph

Review in Nitric oxide : biology and chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Diabetic Nephropathy and Gaseous Modulators.Antioxidants (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Utpal SenDepartment of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40292, United States. Electronic address: u0sen001@louisville.edu.
Sathnur B PushpakumarDepartment of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40292, United States.
Matthew A AminDepartment of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40292, United States.
Suresh C TyagiDepartment of Physiology and Biophysics, University of Louisville School of Medicine, Louisville, KY 40292, United States.
University of Louisville · US

Funding

Homocysteine & Angiotensin II in Renovascular RemodelingR01HL104103 · NHLBI · UNIVERSITY OF LOUISVILLE · PI SEN, UTPAL · 2011 to 2015
$1.8M
NHLBI NIH HHS HL-104103NHLBI NIH HHS R01 HL104103
6 · The paper itself

Abstract

Homocysteine (Hcy) is a non-protein amino acid derived from dietary methionine. High levels of Hcy, known as hyperhomocysteinemia (HHcy) is known to cause vascular complications. In the mammalian tissue, Hcy is metabolized by transsulfuration enzymes to produce hydrogen sulfide (H2S). H2S, a pungent smelling gas was previously known for its toxic effects in the central nervous system, recent studies however has revealed protective effects in a variety of diseases including hypertension, diabetes, inflammation, atherosclerosis, and renal disease progression and failure. Interestingly, under stress conditions including hypoxia, H2S can reduce metabolic demand and also act as a substrate for ATP production. This review highlights some of the recent advances in H2S research as a potential therapeutic agent targeting renovascular diseases associated with HHcy.

Indexed as

HomocysteineHydrogen SulfideKidney DiseasesVascular DiseasesAdenosine TriphosphateAnaerobiosisAnimalsHumansKidneyMiceRatsAdenosine TriphosphateHomocysteineHydrogen SulfideExtracellular matrixHomocysteineHydrogen sulfideHypertensionInflammationMatrix metalloproteinaseMitophagyRenal remodeling

Identifiers

PMID24963795
PMCPMC4156889
OpenAlexW2065502036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.